Skip to content

A clinical research study investigating how the body processes the new compound afabicin in people with kidney problems and people with normal kidney function

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-526916-35-00
Enrollment
60
Registered
2026-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Impairment

Interventions

None listed

Sponsors

Debiopharm International S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 19, 2026